United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$70Mraised across 4 rounds since 2004, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Horizon Technology Finance
Rho VenturesReported by inotekcorp.com
Rho Capital PartnersReported by sec.govSEC filing: $24M sold, first sale Jun 2010
Rho Capital PartnersFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Rho Capital PartnersPitango Venture CapitalDevon Park BioVenturesHorizon Technology FinanceRho VenturesLa Caisse de dépôt et placement du QuébecMissing a round, or an investor who was in one? Tell us.
Inotek Pharmaceuticals's investors include MedImmune Ventures, Care Capital, Rho Capital Partners, Pitango Venture Capital and Devon Park BioVentures, and 3 more on record.
Inotek Pharmaceuticals has raised $70M across 4 rounds since 2004.
Inotek Pharmaceuticals's most recent round was a Debt of $7.0M in Sept 2013.
Inotek Pharmaceuticals's largest round on record is $24M (Series D), in Jul 2011.
Inotek Pharmaceuticals's first round on record, in Apr 2004, was backed by Rho Capital Partners, MedImmune Ventures and Care Capital.
Inotek Pharmaceuticals's latest named round is a Debt, in Sept 2013.
Inotek Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
